NCT00468039View on ClinicalTrials.gov

A Sub-study to LMF237A2302 to Assess the Effect of 24 Weeks Treatment With Initial Combination of Vildagliptin Plus Metformin

PHASE3CompletedINTERVENTIONAL
Enrollment

94

Participants

Timeline

Start Date

March 6, 2007

Primary Completion Date

June 6, 2008

Study Completion Date

June 6, 2008

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

vildagliptin + metformin

Trial Locations (1)

78229

Diabetes and Glandular Disease Research Associates, San Antonio

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY